Hepatitis C virus-associated hepatitis following treatment of HIV-infected patients with HIV protease inhibitors: An immune restoration disease?

AIDS

Volumn 12, Issue 17, 1998, Pages 2289-2293

  John, Mina ^a   Flexman, James ^a   French, Martyn A H ^a  

^a ROYAL PERTH HOSPITAL   (Australia)

Author keywords

Hepatitis; Hepatitis C virus; HIV; Protease inhibitors

Indexed keywords

ALANINE AMINOTRANSFERASE; ANTIRETROVIRUS AGENT; HEPATITIS C ANTIBODY; PROTEINASE; PROTEINASE INHIBITOR; VIRUS RNA;

ACUTE HEPATITIS; ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; CASE REPORT; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIVER BIOPSY; MALE; MEDICAL RECORD; MYCOBACTERIUM INTRACELLULARE AVIUM; PRIORITY JOURNAL;

EID: 0032480896     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-199817000-00010     Document Type: Article

References (14)

1. Hammer SM, Squires KE, Hughes MD, et al.: A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. N Engl J Med 1997, 337:725-733.
2. Jacobson MA, French M: Altered natural history of AIDS-related opportunistic infections in the era of potent combination antiretroviral therapy. AIDS 1997, 12 (suppl A):S157-163.
3. Brau N, Leaf HL, Wieczorek RL, et al.: Severe hepatitis in three AIDS patients treated with indinavir. Lancet 1997, 349:924-925.
4. Matsuda J, Gohchi K, Yamanaka M: Severe hepatitis in patients with AIDS and haemophilia B treated with indinavir [letter]. Lancet 1997, 350:364.
5. Vergis E, Patterson D, Singh N: Indinavir-associated hepatitis in patients with advanced HIV infection. Int J STD AIDS 1998, 9:53.
6. Vento S, Garofano T, Renzini C, et al.: Enhancement of hepatitis C virus replication and liver damage in HIV-coinfected patients on antiretroviral combination therapy [letter]. AIDS 1998, 12:116-117.
7. Carr A, Cooper D: Restoration of immunity to chronic hepatitis B infection in HIV-infected patient on protease inhibitor. Lancet 1997, 340:995-996.
8. French MAH, Mallal SA, Dawkins RL: Zidovudine-induced restoration of cell-mediated immunity to mycobacteria in immunodeficient HIV-infected patients. AIDS 1992, 6:1293-1297.
9. Ockenga J, Tillmann HL, Trautwein C, et al.: Hepatitis B and C in HIV-infected patients. Prevalence and prognostic value. J Hepatol 1997, 27:18-24.
10. Garcia-Samaniego J, Soriano V, Castilla J, et al.: Influence of hepatitis C virus genotypes and HIV infection on histological severity of chronic hepatitis C. The Hepatitis/HIV Spanish Study Group. Am J Gastroenterol 1997, 92:1130-1134.
11. Soto B, Sanchez-Quijano A, Rodrigo L, et al.: Human immunodeficiency virus infection modifies the natural history of chronic parenterally-acquired hepatitis C with an unusually rapid progression to cirrhosis. J Hepatol 1997, 26:1-5.
12. Chamot E, Hirsrhel B, Wintsch J, et al.: Loss of antibodies against hepatitis C virus in HIV-seropositive intravenous drug users. AIDS 1990, 4:1275-1277.
13. Rockstroh K, Albers-Busch U, Schliefer K, et al.: Antiviral combination therapy decreases HIV load but does not alter hepatitis C replication [abstract]. Gastroenterology 1997, 112:A1367.
14. O'Connor WJ, Murphy GM, Darby C, et al.: Porphyrin abnormalities in acquired immunodeficiency syndrome. Arch Dermatol 1996, 132:1443-1447.